sarcopenia semaglutide and muscle strength in older adults | Konstantinos Prokopidis posted on the topic Strategies for minimizing muscle loss
Description
Weight fluctuates daily based on water retention, sodium intake, hormonal cycles, and bowel movements

Semaglutide can cause nausea, vomiting, or reduced appetite, particularly during the early stages of treatment
An oral formulation or device must provide enough systemic uptake from the gastrointestinal tract to demonstrate acceptable value over competing injectable products

While GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro) are usually used at standard doses to lower blood sugar or achieve significant weight loss, microdosing aims to exploit metabolic and anti-inflammatory benefits without the pronounced appetite suppression, nausea, or high costs of full-dose therapy
A perfect addition to your wellness routine
As of July 2026, there were 86 cases pending in MDL-3163
